You are here:

oseltamivir (Tamiflu)

Advice

following an abbreviated submission

oseltamivir (Tamiflu®) is accepted for use within NHS Scotland.

Indication under review: Treatment of influenza in children aged <1 year including full term neonates who present with symptoms typical of influenza, when influenza virus is circulating in the community. Efficacy has been demonstrated when treatment is initiated within two days of first onset of symptoms.

Oseltamivir is listed in the British National Formulary for Children (November 2015) for use in children aged <1 year including neonates.  Oseltamavir has previously been accepted for use for this indication in patients aged ≥1 year in NHS Scotland as NHS Healthcare Improvement Scotland advised that NICE Multiple Technology Appraisal No. 168 was valid for Scotland.

Drug Details

Drug Name: oseltamivir (Tamiflu)
SMC Drug ID: 1127/16
Manufacturer: Roche
Indication: Treatment of influenza in children aged <1 year including full term neonates who present with symptoms typical of influenza, when influenza virus is circulating in the community. Efficacy has been demonstrated when treatment is initiated within two days of first onset of symptoms.
BNF Category:
Sub Category: 5.3 Antiviral Drugs
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 7 March 2016

Back